Status:
NOT_YET_RECRUITING
Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada?
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Autoimmune Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Autologous Hematopoietic Stem Cell Transplantation (AHSCT) is a treatment option for several types of Autoimmune Disease (AD) in patients who remain active despite disease modifying therapies. In this...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years at AHSCT
- Underwent first AHSCT for any AD indication
- Included in the French MATHEC-SFGM-TC registry or the Canadian Ottawa and Calgary databases
- AHSCT between January, 1st, 2000 and December, 31st, 2022
- Informed consent for data registration in the respective original registry/database
Exclusion
- None
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06507800
Start Date
September 1 2024
End Date
September 1 2025
Last Update
July 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.